Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Front Cell Infect Microbiol ; 12: 907519, 2022.
Article in English | MEDLINE | ID: mdl-35982778

ABSTRACT

Damage to the lung epithelium is a unifying feature of disease caused by the saprophytic fungus Aspergillus fumigatus. However, the mechanistic basis and the regulatory control of such damage is poorly characterized. Previous studies have identified A. fumigatus mediated pathogenesis as occurring at early (≤ 16 hours) or late (>16 hours) phases of the fungal interaction with epithelial cells, and respectively involve direct contact with the host cell or the action of soluble factors produced by mature fungal hyphae. Both early and late phases of epithelial damage have been shown to be subject to genetic regulation by the pH-responsive transcription factor PacC. This study sought to determine whether other transcriptional regulators play a role in modulating epithelial damage. In particular, whether the early and late phases of epithelial damage are governed by same or distinct regulators. Furthermore, whether processes such as spore uptake and hyphal adhesion, that have previously been documented to promote epithelial damage, are governed by the same cohorts of epithelial regulators. Using 479 strains from the recently constructed library of A. fumigatus transcription factor null mutants, two high-throughput screens assessing epithelial cell detachment and epithelial cell lysis were conducted. A total of 17 transcription factor mutants were found to exhibit reproducible deficits in epithelial damage causation. Of these, 10 mutants were defective in causing early phase damage via epithelial detachment and 8 mutants were defective in causing late phase damage via epithelial lysis. Remarkably only one transcription factor, PacC, was required for causation of both phases of epithelial damage. The 17 mutants exhibited varied and often unique phenotypic profiles with respect to fitness, epithelial adhesion, cell wall defects, and rates of spore uptake by epithelial cells. Strikingly, 9 out of 10 mutants deficient in causing early phase damage also exhibited reduced rates of hyphal extension, and culture supernatants of 7 out of 8 mutants deficient in late phase damage were significantly less cytotoxic. Our study delivers the first high-level overview of A. fumigatus regulatory genes governing lung epithelial damage, suggesting highly coordinated genetic orchestration of host-damaging activities that govern epithelial damage in both space and time.


Subject(s)
Aspergillosis , Aspergillus fumigatus , Lung , Transcription Factors , Aspergillosis/pathology , Aspergillus fumigatus/genetics , Aspergillus fumigatus/metabolism , Cell Wall/metabolism , Epithelium/microbiology , Epithelium/pathology , Fungal Proteins/genetics , Fungal Proteins/metabolism , Humans , Hyphae/genetics , Hyphae/metabolism , Lung/microbiology , Lung/pathology , Transcription Factors/genetics , Transcription Factors/metabolism
3.
Methods Mol Biol ; 2260: 225-239, 2021.
Article in English | MEDLINE | ID: mdl-33405042

ABSTRACT

Host-pathogen interactions involve a complex interplay between host and pathogen factors, resulting in either host protective immunity or establishment of disease. One of the hallmarks for disease progression is host tissue destruction. The first host surface to interact with the opportunistic respiratory fungal pathogen, Aspergillus fumigatus, is the airway epithelium. Unravelling the mechanisms involved in airway epithelial cell damage by A. fumigatus is essential to understanding the establishment and progression of infection in the host. Although host cell damage can be measured in vitro by indirect cell lysis assays, here, we describe an automated, simple, and low-cost assay to directly visualize and quantify epithelial cell line damage after challenge with A. fumigatus. We employ the previously characterized tissue noninvasive A. fumigatus ΔpacC mutant to demonstrate the quantitative difference in cell damage relative to its parental tissue invasive strain. This assay is easily scaled up for high-throughput screening of multiple Aspergillus mutants and can be adapted to suit diverse host cell lines, different time points of infection, challenge with other microbes, and drugs or novel compounds.


Subject(s)
Aspergillus fumigatus/pathogenicity , Cell Adhesion , Epithelial Cells/microbiology , Lung/microbiology , Microscopy, Fluorescence , Pulmonary Aspergillosis/microbiology , A549 Cells , Aspergillus fumigatus/genetics , Automation, Laboratory , Epithelial Cells/pathology , Fungal Proteins/genetics , High-Throughput Screening Assays , Host-Pathogen Interactions , Humans , Image Interpretation, Computer-Assisted , Lung/pathology , Mutation , Pulmonary Aspergillosis/pathology , Transcription Factors/genetics
4.
Nat Commun ; 11(1): 427, 2020 01 22.
Article in English | MEDLINE | ID: mdl-31969561

ABSTRACT

The frequency of antifungal resistance, particularly to the azole class of ergosterol biosynthetic inhibitors, is a growing global health problem. Survival rates for those infected with resistant isolates are exceptionally low. Beyond modification of the drug target, our understanding of the molecular basis of azole resistance in the fungal pathogen Aspergillus fumigatus is limited. We reasoned that clinically relevant antifungal resistance could derive from transcriptional rewiring, promoting drug resistance without concomitant reductions in pathogenicity. Here we report a genome-wide annotation of transcriptional regulators in A. fumigatus and construction of a library of 484 transcription factor null mutants. We identify 12 regulators that have a demonstrable role in itraconazole susceptibility and show that loss of the negative cofactor 2 complex leads to resistance, not only to the azoles but also the salvage therapeutics amphotericin B and terbinafine without significantly affecting pathogenicity.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus fumigatus/drug effects , Drug Resistance, Fungal , Fungal Proteins/metabolism , Amphotericin B/pharmacology , Aspergillus fumigatus/genetics , Aspergillus fumigatus/metabolism , Azoles/pharmacology , Fungal Proteins/genetics , Microbial Sensitivity Tests
5.
PLoS Pathog ; 15(4): e1007657, 2019 04.
Article in English | MEDLINE | ID: mdl-30998782

ABSTRACT

Helminths are highly prevalent metazoan parasites that infect over a billion of the world's population. Hosts have evolved numerous mechanisms to drive the expulsion of these parasites via Th2-driven immunity, but these responses must be tightly controlled to prevent equally devastating immunopathology. However, mechanisms that regulate this balance are still unclear. Here we show that the vigorous Th2 immune response driven by the small intestinal helminth Trichinella spiralis, is associated with increased TGFß signalling responses in CD4+ T-cells. Mechanistically, enhanced TGFß signalling in CD4+ T-cells is dependent on dendritic cell-mediated TGFß activation which requires expression of the integrin αvß8. Importantly, mice lacking integrin αvß8 on DCs had a delayed ability to expel a T. spiralis infection, indicating an important functional role for integrin αvß8-mediated TGFß activation in promoting parasite expulsion. In addition to maintaining regulatory T-cell responses, the CD4+ T-cell signalling of this pleiotropic cytokine induces a Th17 response which is crucial in promoting the intestinal muscle hypercontractility that drives worm expulsion. Collectively, these results provide novel insights into intestinal helminth expulsion beyond that of classical Th2 driven immunity, and highlight the importance of IL-17 in intestinal contraction which may aid therapeutics to numerous diseases of the intestine.


Subject(s)
Dendritic Cells/immunology , Intestine, Small/immunology , Th17 Cells/immunology , Transforming Growth Factor beta/metabolism , Trichinella spiralis/immunology , Trichinellosis/immunology , Animals , Cells, Cultured , Cytokines/metabolism , Dendritic Cells/cytology , Dendritic Cells/parasitology , Intestine, Small/parasitology , Male , Mice , Mice, Inbred C57BL , Th17 Cells/parasitology , Trichinellosis/parasitology
7.
PLoS Pathog ; 9(10): e1003675, 2013.
Article in English | MEDLINE | ID: mdl-24098124

ABSTRACT

Chronic intestinal parasite infection is a major global health problem, but mechanisms that promote chronicity are poorly understood. Here we describe a novel cellular and molecular pathway involved in the development of chronic intestinal parasite infection. We show that, early during development of chronic infection with the murine intestinal parasite Trichuris muris, TGFß signalling in CD4+ T-cells is induced and that antibody-mediated inhibition of TGFß function results in protection from infection. Mechanistically, we find that enhanced TGFß signalling in CD4+ T-cells during infection involves expression of the TGFß-activating integrin αvß8 by dendritic cells (DCs), which we have previously shown is highly expressed by a subset of DCs in the intestine. Importantly, mice lacking integrin αvß8 on DCs were completely resistant to chronic infection with T. muris, indicating an important functional role for integrin αvß8-mediated TGFß activation in promoting chronic infection. Protection from infection was dependent on CD4+ T-cells, but appeared independent of Foxp3+ Tregs. Instead, mice lacking integrin αvß8 expression on DCs displayed an early increase in production of the protective type 2 cytokine IL-13 by CD4+ T-cells, and inhibition of this increase by crossing mice to IL-4 knockout mice restored parasite infection. Our results therefore provide novel insights into how type 2 immunity is controlled in the intestine, and may help contribute to development of new therapies aimed at promoting expulsion of gut helminths.


Subject(s)
Dendritic Cells/immunology , Integrins/immunology , Intestinal Diseases, Parasitic/immunology , Th2 Cells/immunology , Transforming Growth Factor beta/immunology , Trichuriasis/immunology , Trichuris/immunology , Animals , Chronic Disease , Dendritic Cells/metabolism , Dendritic Cells/pathology , Integrins/genetics , Integrins/metabolism , Interleukin-13/genetics , Interleukin-13/immunology , Interleukin-13/metabolism , Intestinal Diseases, Parasitic/genetics , Intestinal Diseases, Parasitic/pathology , Mice , Mice, Knockout , Th2 Cells/metabolism , Th2 Cells/pathology , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Trichuriasis/genetics , Trichuriasis/metabolism , Trichuriasis/pathology , Trichuris/genetics , Trichuris/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...